Skip to main content
VulnerabilityPublished Updated

CVE-2026-94146: BioStar BIOS Update Utility · Write-what-where Condition

Affects BioStar BIOS Update UtilitySource CVE Database V5

0
Compare

Public exploit available · CVSS 9.3 Critical.

Data as of 5 Nov 2026, 00:01 UTC

CVSS 4.0 base score
9.3Critical
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 7% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 21 Sep 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: evidence found.

    CVSS exploit maturity: proof of concept public

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), CVSS vector, the Metasploit, Exploit-DB and nuclei-templates index as of 5 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
BioStarBIOS Update UtilityAffected
  • =1.9.7.3
Fixed in–

AI-suggested

Users should avoid running the vulnerable version 1.9.7.3 of BioStar BIOS Update Utility until a vendor patch is released. Given the local attack requirement, restricting local access to trusted users and monitoring for suspicious activity may help reduce risk temporarily.

Description

CVE-2026-94146 is a critical write-what-where vulnerability in BioStar BIOS Update Utility version 1.9.7.3. It affects the IOCTL handler function sub_110BC in the BSMEM64_W10.sys driver. The flaw allows local attackers with limited privileges to manipulate physical memory addresses and sizes, potentially leading to arbitrary memory writes. Exploit code has been publicly disclosed, but there is no vendor response or patch available at this time.

References

Community reviews

Loading reviews…